CS logo
small CS logo
ikfe - Institut für klinische Forschung und Entwicklung Berlin GmbH

Berlin, Germany
Studying center in Berlin
Gethsemanestr. 6, Aufgang III, 10437

About ikfe - Institut für klinische Forschung und Entwicklung Berlin GmbH


"Klinische Studien"
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
2
Pfizer
2
Total Rows: 2

Clinical Trials at ikfe - Institut für klinische Forschung und Entwicklung Berlin GmbH


During the past decade, ikfe - Institut für klinische Forschung und Entwicklung Berlin GmbH conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 4 clinical trials were completed, i.e. on average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1100Started TrialsCompleted Trails201500.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
Linagliptin as Add on to Basal Insulin in the Elderly
2014-09-23
2017-04-25
Completed
302
Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-2)
2015-06-30
2017-10-23
Completed
730

Rows per page:

1–4 of 4

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "ikfe - Institut für klinische Forschung und Entwicklung Berlin GmbH" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsBoehringer Ingelheim: 2Boehringer Ingelheim: 2Pfizer: 2Pfizer: 2

Created with Highcharts 11.1.0Top CollaboratorsEli Lilly and Company: 2Eli Lilly and Company: 2

Clinical Trials Conditions at ikfe - Institut für klinische Forschung und Entwicklung Berlin GmbH


According to Clinical.Site data, the most researched conditions in "ikfe - Institut für klinische Forschung und Entwicklung Berlin GmbH" are "Cardiovascular Disease" (2 trials), "Diabetes Mellitus, Type 1" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "ikfe - Institut für klinische Forschung und Entwicklung Berlin GmbH" in a lesser frequency.

Clinical Trials Intervention Types at ikfe - Institut für klinische Forschung und Entwicklung Berlin GmbH


Most popular intervention types in "ikfe - Institut für klinische Forschung und Entwicklung Berlin GmbH" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "bococizumab (PF-04950615)" (2 trials), "Empagliflozin" (1 trials), "linagliptin" (1 trials) and "placebo" (1 trials). Other intervention names were less common.

Clinical Trials Genders at ikfe - Institut für klinische Forschung und Entwicklung Berlin GmbH


The vast majority of trials in "ikfe - Institut für klinische Forschung und Entwicklung Berlin GmbH" are 4 trials for "All" genders.

Clinical Trials Status at ikfe - Institut für klinische Forschung und Entwicklung Berlin GmbH


Currently, there are NaN active trials in "ikfe - Institut für klinische Forschung und Entwicklung Berlin GmbH". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in ikfe - Institut für klinische Forschung und Entwicklung Berlin GmbH, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in ikfe - Institut für klinische Forschung und Entwicklung Berlin GmbH, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 3Phase 3: 3Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 2Completed: 2Terminated: 2Terminated: 2